Tobacco Farm Site Tours Program, 22620-22621 [2016-08900]
Download as PDF
22620
Federal Register / Vol. 81, No. 74 / Monday, April 18, 2016 / Notices
Accreditation Criteria’’ provides
information for those interested in
participating in this voluntary program.
In the Federal Register of October 21,
2015 (80 FR 63806), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. No comments were
received.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Activity
Number of
respondents
Number of
responses per
respondent
Total annual
responses
Average
burden per
response
Total hours
Request for accreditation .....................................................
1
1
1
80
80
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
Dated: April 12, 2016.
Leslie Kux,
Associate Commissioner for Policy.
5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.
FOR FURTHER INFORMATION CONTACT:
Allison Hoffman, Office of Science,
Center for Tobacco Products, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 75, Rm. 5426,
Silver Spring, MD 20993–0002, 1–877–
287–1373, email: CTPRegulations@
fda.hhs.gov.
[FR Doc. 2016–08893 Filed 4–15–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
SUPPLEMENTARY INFORMATION:
[Docket No. FDA–2016–N–1109]
I. Background
Tobacco Farm Site Tours Program
On June 22, 2009, the President
signed the Family Smoking Prevention
and Tobacco Control Act (Pub. L. 111–
31) into law, amending the Federal
Food, Drug, and Cosmetic Act (the
FD&C Act) and giving FDA authority to
regulate tobacco product manufacturing,
distribution, and marketing.
CTP’s Office of Science is conducting
the Tobacco Farm Site Tours Program to
provide its staff an opportunity to visit
farms that grow tobacco for sale to
tobacco product manufacturers (a
‘‘tobacco product manufacturer’’ is
defined as any person, including any
repacker or relabeler, who
manufactures, fabricates, assembles,
processes, or labels a tobacco product,
or imports a finished tobacco product
for sale or distribution in the United
States (section 900(20) of the FD&C Act
(21 U.S.C. 387(20))). Although farms
that grow tobacco are not FDA-regulated
entities unless they are also a tobacco
product manufacturer or controlled by a
tobacco product manufacturer (see
section 901(c)(2) of the FD&C Act (21
U.S.C. 387a(c)(2))), tobacco farm site
visits will aid the Agency in gaining a
better understanding of tobacco farming
and the processes involved in curing
and preparing tobacco leaf intended for
sale to tobacco product manufacturers.
The goal for the Tobacco Farm Site
Tours Program is for CTP staff to gain
firsthand exposure to tobacco farming
practices, including cultivation,
harvesting, curing, and preparation for
sale of tobacco leaf to tobacco product
manufacturers.
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA), Center for
Tobacco Products (CTP), is announcing
an invitation for participation in its
voluntary Tobacco Farm Site Tours
Program. This program is intended to
give CTP staff an opportunity to visit
farms that grow tobacco for sale to
tobacco product manufacturers in order
to gain a better understanding of tobacco
farming and the processes involved in
curing and preparing tobacco intended
for sale to tobacco product
manufacturers. This program is not an
FDA regulatory inspection, and tobacco
farms are not regulated entities unless
they are also a tobacco product
manufacturer or controlled by a tobacco
product manufacturer. The purpose of
this notice is to invite parties interested
in participating in the Tobacco Farm
Site Tours Program to submit requests to
CTP.
DATES: Submit either an electronic or
written request for participation in this
program by June 17, 2016. See section
IV of this document for information on
requests for participation.
ADDRESSES: If your farm is interested in
offering a site visit, please submit a
request either electronically to https://
www.regulations.gov or in writing to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:54 Apr 15, 2016
Jkt 238001
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
II. Description of Tobacco Farm Site
Tours Program
In the Tobacco Farm Site Tours
Program, small groups of CTP staff plan
to observe the operations of farms that
grow tobacco for sale to tobacco product
manufacturers. Please note that FDA
does not regulate these farms and the
Tobacco Farm Site Tours Program is not
an inspection of facilities to determine
compliance with the FD&C Act; rather,
this program is meant to educate CTP
staff and improve their understanding of
tobacco farming. It is anticipated that
the tobacco farm site tours will take
place in the fall of 2016.
III. Site Selection
CTP hopes to be able to tour small,
medium, and large farms, and farms that
grow tobacco for different kinds of
tobacco products. Final site selections
will be based on the availability of
funds and resources for the relevant
fiscal year as well as the desire to visit
a wide variety of types of tobacco farms.
FDA plans on visiting nine or fewer
farms. All FDA travel expenses
associated with the farm site tours will
be the responsibility of FDA.
IV. Requests for Participation
To aid in site selection, your request
for participation should include the
following information:
• A description of your farm,
including the size of the farm;
• A list of the type(s) of tobacco
grown and the kinds of tobacco product
manufacturers to whom you sell
tobacco;
• The physical address(es) of the
site(s) for which you are submitting a
request; and
• A proposed 1-day tour agenda.
Identify requests for participation
with the docket number found in
brackets in the heading of this
document. Received requests are
available for public examination in the
Division of Dockets Management (see
ADDRESSES) between 9 a.m. and 4 p.m.,
Monday through Friday.
E:\FR\FM\18APN1.SGM
18APN1
22621
Federal Register / Vol. 81, No. 74 / Monday, April 18, 2016 / Notices
Dated: April 12, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016–08900 Filed 4–15–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection: Public
Comment Request
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
In compliance with the
requirement for opportunity for public
comment on proposed data collection
projects (Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995), the
Health Resources and Services
Administration (HRSA) announces
plans to submit an Information
Collection Request (ICR), described
below, to the Office of Management and
Budget (OMB). Prior to submitting the
ICR to OMB, HRSA seeks comments
from the public regarding the burden
estimate, below, or any other aspect of
the ICR.
DATES: Comments on this Information
Collection Request must be received no
later than June 17, 2016.
ADDRESSES: Submit your comments to
paperwork@hrsa.gov or mail the HRSA
SUMMARY:
Information Collection Clearance
Officer, Room 14N–39, Parklawn
Building, 5600 Fishers Lane, Rockville,
MD 20857.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call the HRSA Information Collection
Clearance Officer at (301) 443–1984.
SUPPLEMENTARY INFORMATION: When
submitting comments or requesting
information, please include the
information request collection title for
reference.
Information Collection Request Title:
Black Lung Clinics Program
Performance Measures
OMB No. 0915–0292—Extension.
Abstract: The Federal Office of Rural
Health Policy (FORHP), HRSA,
conducts an annual data collection of
user information for the Black Lung
Clinics Program, which has been
ongoing with OMB approval since 2004.
The purpose of the Black Lung Clinics
Program is to reduce the morbidity and
mortality associated with
occupationally related coal mine dust
lung disease through the screening,
diagnosis, and treatment of active,
inactive, retired, and/or disabled coal
miners. Collecting this data provides
HRSA with information on how well
each grantee is meeting the needs of
these miners in their communities.
Need and Proposed Use of the
Information: Data from the annual
report provides quantitative information
about the clinics, specifically: (a) The
characteristics of the patients they serve
(gender, age, disability level, occupation
type); (b) the characteristics of services
provided (medical encounters, nonmedical encounters, benefits
counseling, and outreach); and, (c) the
number of patients served. This
assessment enables HRSA to provide
data required by Congress under the
Government Performance and Results
Act of 1993. It also ensures that funds
are effectively used to provide services
that meet the target population needs.
HRSA does not plan to make any
changes to the performance measures at
this time.
Likely Respondents: Black Lung
Clinics Program Grantees.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this Information
Collection Request are summarized in
the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
15
1
15
10
150
Total ..............................................................................
mstockstill on DSK4VPTVN1PROD with NOTICES
Black Lung Clinics Program Measures ...............................
15
1
15
10
150
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
VerDate Sep<11>2014
17:54 Apr 15, 2016
Jkt 238001
technology to minimize the information
collection burden.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Jackie Painter,
Director, Division of the Executive Secretariat.
National Institutes of Health
[FR Doc. 2016–08802 Filed 4–15–16; 8:45 am]
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
BILLING CODE 4165–15–P
PO 00000
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
Frm 00055
Fmt 4703
Sfmt 4703
E:\FR\FM\18APN1.SGM
18APN1
Agencies
[Federal Register Volume 81, Number 74 (Monday, April 18, 2016)]
[Notices]
[Pages 22620-22621]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-08900]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2016-N-1109]
Tobacco Farm Site Tours Program
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA), Center for Tobacco
Products (CTP), is announcing an invitation for participation in its
voluntary Tobacco Farm Site Tours Program. This program is intended to
give CTP staff an opportunity to visit farms that grow tobacco for sale
to tobacco product manufacturers in order to gain a better
understanding of tobacco farming and the processes involved in curing
and preparing tobacco intended for sale to tobacco product
manufacturers. This program is not an FDA regulatory inspection, and
tobacco farms are not regulated entities unless they are also a tobacco
product manufacturer or controlled by a tobacco product manufacturer.
The purpose of this notice is to invite parties interested in
participating in the Tobacco Farm Site Tours Program to submit requests
to CTP.
DATES: Submit either an electronic or written request for participation
in this program by June 17, 2016. See section IV of this document for
information on requests for participation.
ADDRESSES: If your farm is interested in offering a site visit, please
submit a request either electronically to https://www.regulations.gov or
in writing to the Division of Dockets Management (HFA-305), Food and
Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Allison Hoffman, Office of Science,
Center for Tobacco Products, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 75, Rm. 5426, Silver Spring, MD 20993-0002, 1-
877-287-1373, email: CTPRegulations@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
On June 22, 2009, the President signed the Family Smoking
Prevention and Tobacco Control Act (Pub. L. 111-31) into law, amending
the Federal Food, Drug, and Cosmetic Act (the FD&C Act) and giving FDA
authority to regulate tobacco product manufacturing, distribution, and
marketing.
CTP's Office of Science is conducting the Tobacco Farm Site Tours
Program to provide its staff an opportunity to visit farms that grow
tobacco for sale to tobacco product manufacturers (a ``tobacco product
manufacturer'' is defined as any person, including any repacker or
relabeler, who manufactures, fabricates, assembles, processes, or
labels a tobacco product, or imports a finished tobacco product for
sale or distribution in the United States (section 900(20) of the FD&C
Act (21 U.S.C. 387(20))). Although farms that grow tobacco are not FDA-
regulated entities unless they are also a tobacco product manufacturer
or controlled by a tobacco product manufacturer (see section 901(c)(2)
of the FD&C Act (21 U.S.C. 387a(c)(2))), tobacco farm site visits will
aid the Agency in gaining a better understanding of tobacco farming and
the processes involved in curing and preparing tobacco leaf intended
for sale to tobacco product manufacturers. The goal for the Tobacco
Farm Site Tours Program is for CTP staff to gain firsthand exposure to
tobacco farming practices, including cultivation, harvesting, curing,
and preparation for sale of tobacco leaf to tobacco product
manufacturers.
II. Description of Tobacco Farm Site Tours Program
In the Tobacco Farm Site Tours Program, small groups of CTP staff
plan to observe the operations of farms that grow tobacco for sale to
tobacco product manufacturers. Please note that FDA does not regulate
these farms and the Tobacco Farm Site Tours Program is not an
inspection of facilities to determine compliance with the FD&C Act;
rather, this program is meant to educate CTP staff and improve their
understanding of tobacco farming. It is anticipated that the tobacco
farm site tours will take place in the fall of 2016.
III. Site Selection
CTP hopes to be able to tour small, medium, and large farms, and
farms that grow tobacco for different kinds of tobacco products. Final
site selections will be based on the availability of funds and
resources for the relevant fiscal year as well as the desire to visit a
wide variety of types of tobacco farms. FDA plans on visiting nine or
fewer farms. All FDA travel expenses associated with the farm site
tours will be the responsibility of FDA.
IV. Requests for Participation
To aid in site selection, your request for participation should
include the following information:
A description of your farm, including the size of the
farm;
A list of the type(s) of tobacco grown and the kinds of
tobacco product manufacturers to whom you sell tobacco;
The physical address(es) of the site(s) for which you are
submitting a request; and
A proposed 1-day tour agenda.
Identify requests for participation with the docket number found in
brackets in the heading of this document. Received requests are
available for public examination in the Division of Dockets Management
(see ADDRESSES) between 9 a.m. and 4 p.m., Monday through Friday.
[[Page 22621]]
Dated: April 12, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-08900 Filed 4-15-16; 8:45 am]
BILLING CODE 4164-01-P